Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

A DNA vaccine delivery platform based on Elastin-Like Recombinamer nanosystems for Rift Valley fever virus.

Gonzalez-Valdivieso J, Borrego B, Girotti A, Moreno S, Brun A, Bermejo-Martin JF, Arias FJ.

Mol Pharm. 2020 Apr 1. doi: 10.1021/acs.molpharmaceut.0c00054. [Epub ahead of print]

PMID:
32233501
2.

MVA Vectored Vaccines Encoding Rift Valley Fever Virus Glycoproteins Protect Mice against Lethal Challenge in the Absence of Neutralizing Antibody Responses.

López-Gil E, Moreno S, Ortego J, Borrego B, Lorenzo G, Brun A.

Vaccines (Basel). 2020 Feb 12;8(1). pii: E82. doi: 10.3390/vaccines8010082.

3.

A bivalent B-cell epitope dendrimer peptide can confer long-lasting immunity in swine against foot-and-mouth disease.

Cañas-Arranz R, Forner M, Defaus S, Rodríguez-Pulido M, de León P, Torres E, Bustos MJ, Borrego B, Sáiz M, Blanco E, Andreu D, Sobrino F.

Transbound Emerg Dis. 2020 Jan 28. doi: 10.1111/tbed.13497. [Epub ahead of print]

PMID:
31994334
4.

Lethal Mutagenesis of Rift Valley Fever Virus Induced by Favipiravir.

Borrego B, de Ávila AI, Domingo E, Brun A.

Antimicrob Agents Chemother. 2019 Jul 25;63(8). pii: e00669-19. doi: 10.1128/AAC.00669-19. Print 2019 Aug.

5.

Preserved immunogenicity of an inactivated vaccine based on foot-and-mouth disease virus particles with improved stability.

Caridi F, Vázquez-Calvo Á, Borrego B, McCullough K, Summerfield A, Sobrino F, Martín-Acebes MA.

Vet Microbiol. 2017 May;203:275-279. doi: 10.1016/j.vetmic.2017.03.031. Epub 2017 Mar 30.

PMID:
28619156
6.

Toxicity of silver nanoparticles in biological systems: Does the complexity of biological systems matter?

Vazquez-Muñoz R, Borrego B, Juárez-Moreno K, García-García M, Mota Morales JD, Bogdanchikova N, Huerta-Saquero A.

Toxicol Lett. 2017 Jul 5;276:11-20. doi: 10.1016/j.toxlet.2017.05.007. Epub 2017 May 5. Review.

PMID:
28483428
7.

Combined administration of synthetic RNA and a conventional vaccine improves immune responses and protection against foot-and-mouth disease virus in swine.

Borrego B, Blanco E, Rodríguez Pulido M, Mateos F, Lorenzo G, Cardillo S, Smitsaart E, Sobrino F, Sáiz M.

Antiviral Res. 2017 Jun;142:30-36. doi: 10.1016/j.antiviral.2017.03.009. Epub 2017 Mar 16.

PMID:
28315707
8.

Potential application of silver nanoparticles to control the infectivity of Rift Valley fever virus in vitro and in vivo.

Borrego B, Lorenzo G, Mota-Morales JD, Almanza-Reyes H, Mateos F, López-Gil E, de la Losa N, Burmistrov VA, Pestryakov AN, Brun A, Bogdanchikova N.

Nanomedicine. 2016 Jul;12(5):1185-92. doi: 10.1016/j.nano.2016.01.021. Epub 2016 Mar 10.

PMID:
26970026
9.

Synthetic RNAs Mimicking Structural Domains in the Foot-and-Mouth Disease Virus Genome Elicit a Broad Innate Immune Response in Porcine Cells Triggered by RIG-I and TLR Activation.

Borrego B, Rodríguez-Pulido M, Revilla C, Álvarez B, Sobrino F, Domínguez J, Sáiz M.

Viruses. 2015 Jul 17;7(7):3954-73. doi: 10.3390/v7072807.

10.

Protection against Rift Valley fever virus infection in mice upon administration of interferon-inducing RNA transcripts from the FMDV genome.

Lorenzo G, Rodríguez-Pulido M, López-Gil E, Sobrino F, Borrego B, Sáiz M, Brun A.

Antiviral Res. 2014 Sep;109:64-7. doi: 10.1016/j.antiviral.2014.06.010. Epub 2014 Jun 25.

PMID:
24973761
11.

A single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection.

López-Gil E, Lorenzo G, Hevia E, Borrego B, Eiden M, Groschup M, Gilbert SC, Brun A.

PLoS Negl Trop Dis. 2013 Jul 11;7(7):e2309. doi: 10.1371/journal.pntd.0002309. Print 2013.

12.

Delivery of synthetic RNA can enhance the immunogenicity of vaccines against foot-and-mouth disease virus (FMDV) in mice.

Borrego B, Rodríguez-Pulido M, Mateos F, de la Losa N, Sobrino F, Sáiz M.

Vaccine. 2013 Sep 13;31(40):4375-81. doi: 10.1016/j.vaccine.2013.07.008. Epub 2013 Jul 13.

PMID:
23859841
13.

Co-expression of the Bcl-xL antiapoptotic protein enhances the induction of Th1-like immune responses in mice immunized with DNA vaccines encoding FMDV B and T cell epitopes.

Gülçe İz S, Döşkaya M, Borrego B, Rodriguez F, Gürüz Y, Gürhan ID.

Vet Res Commun. 2013 Sep;37(3):187-96. doi: 10.1007/s11259-013-9560-3. Epub 2013 Mar 13.

PMID:
23483312
14.

Protection against West Nile virus infection in mice after inoculation with type I interferon-inducing RNA transcripts.

Rodríguez-Pulido M, Martín-Acebes MA, Escribano-Romero E, Blázquez AB, Sobrino F, Borrego B, Sáiz M, Saiz JC.

PLoS One. 2012;7(11):e49494. doi: 10.1371/journal.pone.0049494. Epub 2012 Nov 14.

15.

Modulation of foot-and-mouth disease virus pH threshold for uncoating correlates with differential sensitivity to inhibition of cellular Rab GTPases and decreases infectivity in vivo.

Vázquez-Calvo Á, Caridi F, Rodriguez-Pulido M, Borrego B, Sáiz M, Sobrino F, Martín-Acebes MA.

J Gen Virol. 2012 Nov;93(Pt 11):2382-2386. doi: 10.1099/vir.0.045419-0. Epub 2012 Aug 8.

PMID:
22875255
16.

Inoculation of newborn mice with non-coding regions of foot-and-mouth disease virus RNA can induce a rapid, solid and wide-range protection against viral infection.

Rodríguez-Pulido M, Sobrino F, Borrego B, Sáiz M.

Antiviral Res. 2011 Dec;92(3):500-4. doi: 10.1016/j.antiviral.2011.10.005. Epub 2011 Oct 13.

PMID:
22020303
17.

A DNA vaccine encoding foot-and-mouth disease virus B and T-cell epitopes targeted to class II swine leukocyte antigens protects pigs against viral challenge.

Borrego B, Argilaguet JM, Pérez-Martín E, Dominguez J, Pérez-Filgueira M, Escribano JM, Sobrino F, Rodriguez F.

Antiviral Res. 2011 Nov;92(2):359-63. doi: 10.1016/j.antiviral.2011.07.017. Epub 2011 Jul 26.

PMID:
21820470
18.

Enhancing DNA immunization by targeting ASFV antigens to SLA-II bearing cells.

Argilaguet JM, Pérez-Martín E, Gallardo C, Salguero FJ, Borrego B, Lacasta A, Accensi F, Díaz I, Nofrarías M, Pujols J, Blanco E, Pérez-Filgueira M, Escribano JM, Rodríguez F.

Vaccine. 2011 Jul 26;29(33):5379-85. doi: 10.1016/j.vaccine.2011.05.084. Epub 2011 Jun 14.

PMID:
21679736
19.

RNA structural domains in noncoding regions of the foot-and-mouth disease virus genome trigger innate immunity in porcine cells and mice.

Rodríguez-Pulido M, Borrego B, Sobrino F, Sáiz M.

J Virol. 2011 Jul;85(13):6492-501. doi: 10.1128/JVI.00599-11. Epub 2011 Apr 27.

20.

Current strategies for subunit and genetic viral veterinary vaccine development.

Brun A, Bárcena J, Blanco E, Borrego B, Dory D, Escribano JM, Le Gall-Reculé G, Ortego J, Dixon LK.

Virus Res. 2011 Apr;157(1):1-12. doi: 10.1016/j.virusres.2011.02.006. Epub 2011 Feb 21. Review.

PMID:
21316403
21.

DNA immunization of pigs with foot-and-mouth disease virus minigenes: from partial protection to disease exacerbation.

Ganges L, Borrego B, Fernández-Pacheco P, Revilla C, Fernández-Borges N, Domínguez J, Sobrino F, Rodriguez F.

Virus Res. 2011 Apr;157(1):121-5. doi: 10.1016/j.virusres.2011.02.003. Epub 2011 Feb 17.

PMID:
21315115
22.

Development and characterization of monoclonal antibodies against Rift Valley fever virus nucleocapsid protein generated by DNA immunization.

Martín-Folgar R, Lorenzo G, Boshra H, Iglesias J, Mateos F, Borrego B, Brun A.

MAbs. 2010 May-Jun;2(3):275-84. Epub 2010 May 2.

23.

RNA immunization can protect mice against foot-and-mouth disease virus.

Pulido MR, Sobrino F, Borrego B, Sáiz M.

Antiviral Res. 2010 Mar;85(3):556-8. doi: 10.1016/j.antiviral.2009.12.005. Epub 2009 Dec 18.

PMID:
20005905
24.

Attenuated foot-and-mouth disease virus RNA carrying a deletion in the 3' noncoding region can elicit immunity in swine.

Rodríguez Pulido M, Sobrino F, Borrego B, Sáiz M.

J Virol. 2009 Apr;83(8):3475-85. doi: 10.1128/JVI.01836-08. Epub 2009 Feb 11.

25.

Subcellular distribution of swine vesicular disease virus proteins and alterations induced in infected cells: a comparative study with foot-and-mouth disease virus and vesicular stomatitis virus.

Martín-Acebes MA, González-Magaldi M, Rosas MF, Borrego B, Brocchi E, Armas-Portela R, Sobrino F.

Virology. 2008 May 10;374(2):432-43. doi: 10.1016/j.virol.2007.12.042. Epub 2008 Feb 14.

26.

Recent advances in the development of recombinant vaccines against classical swine fever virus: cellular responses also play a role in protection.

Ganges L, Núñez JI, Sobrino F, Borrego B, Fernández-Borges N, Frías-Lepoureau MT, Rodríguez F.

Vet J. 2008 Aug;177(2):169-77. Epub 2007 Sep 4. Review.

PMID:
17804267
27.

DNA immunization with 2C FMDV non-structural protein reveals the presence of an immunodominant CD8+, CTL epitope for Balb/c mice.

Barfoed AM, Rodriguez F, Therrien D, Borrego B, Sobrino F, Kamstrup S.

Antiviral Res. 2006 Dec;72(3):178-89. Epub 2006 Jul 21.

PMID:
16890298
28.

DNA vaccines expressing B and T cell epitopes can protect mice from FMDV infection in the absence of specific humoral responses.

Borrego B, Fernandez-Pacheco P, Ganges L, Domenech N, Fernandez-Borges N, Sobrino F, Rodríguez F.

Vaccine. 2006 May 1;24(18):3889-99. Epub 2006 Mar 3.

PMID:
16563575
29.

Genomic and antigenic characterization of viruses from the 1993 Italian foot-and-mouth disease outbreak.

Núñez JI, Fusi P, Borrego B, Brocchi E, Pacciarini ML, Sobrino F.

Arch Virol. 2006 Jan;151(1):127-42. Epub 2005 Aug 12.

PMID:
16096711
30.

Adaptability costs in immune escape variants of vesicular stomatitis virus.

Novella IS, Gilbertson DL, Borrego B, Domingo E, Holland JJ.

Virus Res. 2005 Jan;107(1):27-34.

PMID:
15567030
31.

Mapping of linear epitopes on the capsid proteins of swine vesicular disease virus using monoclonal antibodies.

Borrego B, García-Ranea JA, Douglas A, Brocchi E.

J Gen Virol. 2002 Jun;83(Pt 6):1387-1395. doi: 10.1099/0022-1317-83-6-1387.

PMID:
12029154
32.

Characterization of neutralization sites on the circulating variant of swine vesicular disease virus (SVDV): a new site is shared by SVDV and the related coxsackie B5 virus.

Borrego B, Carra E, García-Ranea JA, Brocchi E.

J Gen Virol. 2002 Jan;83(Pt 1):35-44. doi: 10.1099/0022-1317-83-1-35.

PMID:
11752698
33.

Complementation of P37 (F13L gene) knock-out in vaccinia virus by a cell line expressing the gene constitutively.

Borrego B, Lorenzo MM, Blasco R.

J Gen Virol. 1999 Feb;80 ( Pt 2):425-432. doi: 10.1099/0022-1317-80-2-425.

PMID:
10073703
34.

Combinatorial libraries by cassette mutagenesis.

Borrego B, Wienecke A, Schwienhorst A.

Nucleic Acids Res. 1995 May 25;23(10):1834-5. No abstract available.

35.

A highly divergent antigenic site of foot-and-mouth disease virus retains its immunodominance.

Borrego B, Camarero JA, Mateu MG, Domingo E.

Viral Immunol. 1995;8(1):11-8.

PMID:
8546800
36.

New observations on antigenic diversification of RNA viruses. Antigenic variation is not dependent on immune selection.

Domingo E, Díez J, Martínez MA, Hernández J, Holguín A, Borrego B, Mateu MG.

J Gen Virol. 1993 Oct;74 ( Pt 10):2039-45. Review. Erratum in: J Gen Virol 1994 Apr;75(Pt 4):949.

PMID:
7691985
37.
38.

Supplemental Content

Loading ...
Support Center